Septic Arthritis in CKD Patients

Why CKD Changes Everything

1. Uremia-induced immune dysfunction - uremia impairs polymorphonuclear (PMN) cell chemotaxis, phagocytosis, and oxidative burst, producing a functional immunocompromised state even without immunosuppressive drugs. Goldman-Cecil explicitly lists uremia among the metabolic conditions contributing to the "net state of immunosuppression."
2. Repeated vascular access - patients on hemodialysis have percutaneous vascular access established several times weekly, creating a portal of entry for S. aureus bacteremia and subsequent hematogenous seeding of joints. The frequency of septic arthritis in hemodialysis patients is "much increased compared with the general population." (Rheumatology, 2-Volume Set, Elsevier 2022)
3. Comorbidity burden - CKD frequently coexists with diabetes, vascular disease, and immunosuppression, each of which independently elevates risk.
4. Atypical presentation - the uremic immunocompromised state blunts the febrile response and inflammatory markers. The synovial WBC count may be below the usual 50,000/µL threshold despite true infection.

Epidemiology & Organisms

Diagnostic Challenges in CKD

Attenuated Inflammatory Response

• CKD patients may lack fever (>80% of immunocompetent adults have fever; this proportion is lower in the immunocompromised/CKD population)
• ESR and CRP are chronically elevated at baseline in CKD, reducing their diagnostic specificity
• A synovial WBC count < 50,000/µL does NOT exclude septic arthritis in immunocompromised patients - this is a critical pitfall

Diagnostic Mimics in CKD (especially relevant)

1. β2-microglobulin amyloid arthropathy - occurs with long-term HD; amyloid deposits cause joint swelling, carpal tunnel, destructive arthropathy. Synovial fluid cell count may be inflammatory.
2. Crystal arthropathy - CKD predisposes to gout (urate retention) and pseudogout (calcium pyrophosphate). In CKD, however, crystal presence does NOT exclude septic arthritis - both can coexist when synovial WBC > 50,000/µL.
3. Calcium hydroxyapatite deposition - especially peri-articular in HD patients
4. Calcium oxalate arthropathy - in dialysis patients (excess oxalate from vitamin C metabolism)
5. Erosive enthesopathy from secondary hyperparathyroidism
6. Reactive arthritis from recurrent UTIs/bacteremic episodes common in CKD

Diagnostic Algorithm (Goldman-Cecil, 2024)

Arthrocentesis is Mandatory

• Synovial fluid: appearance (cloudy/purulent), leukocyte count + differential, crystal analysis, Gram stain, aerobic + anaerobic + fungal + mycobacterial culture
• Blood cultures: positive in up to 90% of nongonococcal septic arthritis
• In CKD with HD and line-associated bacteremia: also culture the access site
• Ultrasound or CT-guided aspiration for deep joints (hip, sacroiliac)
• The Gram stain is positive in fewer than 50% - a negative result does not rule out infection
• PCR of synovial fluid is increasingly useful, especially when prior antibiotics have been given

Treatment

General Principle

Antibiotic Selection

CKD-Specific Drug Dose Adjustments

"Doses shown are based on normal renal and hepatic function and may need to be adjusted or serum levels monitored (vancomycin)." - Goldman-Cecil, Table 251-2 footnote

Duration of Therapy

• Uncomplicated, susceptible organism, non-immunocompromised: 2 weeks (post-drainage)
• CKD/immunocompromised, abnormal joint, MRSA, gram-negative, or complicating osteomyelitis/bacteremia/endocarditis: 4 to 6 weeks (Firestein & Kelley's Textbook of Rheumatology)
• Consider IV-to-oral switch after 2 weeks if clinical improvement + inflammatory markers falling + bioavailable oral agent available
• Immunosuppression and lack of surgical intervention are associated with recurrence

Joint Drainage

• Serial needle aspiration is first-line for most accessible joints
• Surgical drainage is indicated for:
  • Hip joint (always)
  • Failure to respond to serial aspiration + antibiotics
  • Developing life-threatening complications (e.g., necrotizing fasciitis)
• Arthroscopic lavage is an option where available
• Early mobilisation to prevent contractures

Prognosis in CKD

• ~40% of all septic arthritis patients have less than complete recovery
• CKD worsens outcomes through delayed diagnosis, higher MRSA burden, impaired healing
• S. aureus infection alone carries >50% poor joint outcomes and 10-15% mortality - this rate is further elevated in immunocompromised/CKD patients
• Polyarticular sepsis (more common in immunocompromised patients including CKD) carries especially high mortality

Special Considerations: Dialysis-Related Arthropathy

Key Clinical Pearls for CKD

1. Don't rely on fever or high WBC to diagnose - both may be blunted in uremia
2. Don't rely on a "low" synovial WBC to exclude - counts < 50,000/µL can still represent infection in CKD
3. Cover MRSA empirically - hemodialysis is a major risk factor
4. Crystal arthritis + infection can coexist - crystals in synovial fluid do not exclude septic arthritis
5. Adjust all renally-cleared antibiotics - vancomycin requires TDM; avoid or carefully dose aminoglycosides
6. Extend antibiotic duration - 4-6 weeks in immunocompromised/CKD hosts
7. Always culture blood + dialysis access site - hematogenous spread from access is a common source
8. Screen for endocarditis - S. aureus bacteremia in HD patients has high rates of endocarditis; consider echocardiography

• Goldman-Cecil Medicine, International Edition (PMID-linked textbook, Section 251)
• Harrison's Principles of Internal Medicine, 22nd Ed, 2025 (Chapter on nongonococcal bacterial arthritis)
• Firestein & Kelley's Textbook of Rheumatology (Antibiotic therapy chapter)
• Rheumatology, 2-Volume Set, Elsevier 2022 (Dialysis-related arthropathy section)
• Campbell's Operative Orthopaedics, 15th Ed 2026 (MRSA risk factors)
• Khudair A et al. "The prognostic implications of comorbidities in septic arthritis." Front Med (Lausanne) 2025. PMID: 40800124